Neurocrine Biosciences NBIX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $197.9M+28.8% | $153.7M-26.6% | $209.5M+94.9% | $107.5M+1,261% | $7.9M-92.3% | ||
| $7.2M+12.5% | $6.4M-4.5% | $6.7M+6.3% | $6.3M-4.5% | $6.6M+6.5% | ||
| $57.2M-2.4% | $58.6M+9.1% | $53.7M+1.7% | $52.8M0.0% | $52.8M-20.5% | ||
| $145.8M-62.5% | $388.4M+70.7% | $227.5M+123% | $102M+57.4% | $64.8M-73.3% | ||
| $9.1M— | $0-100% | $13.2M+5.6% | $12.5M+16.8% | $10.7M+46.6% | ||
| -$506.2M-857% | -$52.9M+73.1% | -$196.7M-578% | -$29M-304% | $14.2M+121% | ||
| $54M— | —— | —— | $17.7M-88.2% | $150M-50.0% | ||
| -$86.1M— | —— | —— | -$3.3M+97.2% | -$117.9M+59.3% | ||
| -$446.5M-220% | $372.8M+389% | $76.2M+9.0% | $69.9M+280% | -$38.9M+66.5% | ||
| $136.7M-65.0% | $390.8M+82.4% | $214.3M+139% | $89.5M+65.4% | $54.1M-77.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Neurocrine Biosciences generate?
- Neurocrine Biosciences (NBIX) generated $863.7M in operating cash flow over the trailing twelve months.
- What is Neurocrine Biosciences's free cash flow?
- After $34.8M of capital expenditures, Neurocrine Biosciences's free cash flow was $831.3M over the trailing twelve months, up 68.9% year over year.
- Where does Neurocrine Biosciences's cash flow data come from?
- Every line is extracted from Neurocrine Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
